| Literature DB >> 32214935 |
Melody E Roelke1, Warren E Johnson2, Javier Millán3, Francisco Palomares3, Eloy Revilla3, Alejandro Rodríguez3, Javier Calzada4, Pablo Ferreras5, Luis León-Vizcaíno6, Miguel Delibes3, Stephen J O'Brien2.
Abstract
The Iberian lynx (Lynx pardinus) is the most endangered felid species in the world. Lynx populations have decreased dramatically in size and distribution in the last four decades, thus becoming increasingly vulnerable to catastrophic events such as epizooties. From 1989 to 2000, serum samples were obtained from 48 free-ranging lynx captured in the Doñana National Park (DNP, n = 31) and mountains of Sierra Morena (SM, n = 17) in southern Spain. Samples were tested for antibodies against Toxoplasma gondii, feline herpesvirus 1 (FHV-1), feline calicivirus (FCV), feline/canine parvovirus (FPV/CPV), feline coronavirus, feline immunodeficiency virus (FIV), feline leukaemia virus and canine distemper virus (CDV) and for FeLV p27 antigen, to document baseline exposure levels. Antibodies against T. gondii were detected in 44% of lynx, with a significantly greater prevalence in DNP (61%) than in SM (12%). In DNP, prevalence was significantly higher in adult (81%) than in juvenile and sub-adult (41%) lynx, but no such difference was observed in SM. Low prevalences (≤11%) of minimally positive titres were found for FHV-1, FCV and FPV/CPV. This, combined with the lack of evidence for exposure to CDV, FIV and FeLV, suggests that these lynx populations are naïve and might be vulnerable to a disease outbreak in the future. Because of the reduced size of lynx populations, the documented low level of genetic variation (particularly in the DNP population) coupled with the recently documented state of immune depletion in a majority of necropsied lynx, it is important to better understand the threat and potential impact that disease agents might pose for the conservation of this endangered species. Future surveillance programs must include possible disease reservoir hosts such as domestic cats and dogs and other wild carnivores. © Springer-Verlag 2007.Entities:
Keywords: Andalusia; Conservation; Disease risk; Serosurvey; Spain
Year: 2007 PMID: 32214935 PMCID: PMC7087597 DOI: 10.1007/s10344-007-0122-2
Source DB: PubMed Journal:
Disease agents tested in free-ranging Iberian lynx sera, test method, threshold, and reference or manufacturer and kit number
| Serologic tests run | Number tested | Laba | Assayb | Detects | Criterion and titre | References or manufacturerc, name and number of kit |
|---|---|---|---|---|---|---|
|
| 47 | W | IHA test | IgG | Positive ≥1:64 | Lappin and Powell ( |
| 10 | S | LA | IgG | Positive ≥1:25 | Mazumder et al. ( | |
| Feline herpesvirus-1 | 35 | W | VN test | IgG | Positive ≥1:4 | Scott ( |
| 10 | S | ELISA | IgG | Qualitative | Eurovet: F107-AB02d | |
| Feline calicivirus | 34 | W | VN test | IgG | Positive ≥1:4 | Scott ( |
| 10 | S | ELISA | IgG | Qualitative | Eurovet: F1008-AB02d | |
| Feline/canine parvovirus | 27 | W | IFA test | IgG | Positive ≥1:25 | Scott et al. |
| 10 | S | ELISA | IgG | Qualitative | Ingezim CPV© 15.CPV.K1e | |
| Feline coronavirus | 27 | W | IFA test | IgG | Positive ≥1:25 | Evermann et al. |
| 10 | S | ELISA | IgG | Qualitative | Ingezim FCoV© 16.FCV.K1e | |
| Feline leukaemia virus | 28 | W | ELISA | Antigen p27 | Qualitative | Mia et al. |
| 10 | S | ELISA | Antigen p27 | Qualitative | Ingezim FeLV-Das© 16.FLV.K2e | |
| 10 | S | ELISA | IgG | Qualitative | Ingezim FeLV gp-70© 16.FLV.K1e | |
| Feline immunodeficiency virus | 28 | N | WB | IgG | Qualitative | Troyer et al. |
| 28 | W | ELISA | IgG | Qualitative | Barr et al. | |
| 10 | S | ELISA | IgG | Qualitative | Ingezim FIV© 16.FIV.K1e | |
| Canine distemper virus | 27 | W | VN test | IgG | Positive ≥1:64 | OIE |
| 10 | S | ELISA | IgG | Qualitative | Ingezim Moquillo IgG® 15.CDG.K1e |
aN Laboratory of Genomic diversity, National Cancer Institute, Frederick, MD; S Faculty of Veterinary Medicine, University of Murcia, Spain; W Washington Animal Disease Diagnostic Laboratory, Washington State University, Pullman, WA
bELISA Enzyme-linked immunosorbent assay, IFA indirect immunofluorescence assay; IHA indirect haemagglutination, LA latex agglutination, VN virus neutralisation, WB Western blot
cEurovet Veterinaria (d), Daganzo-Madrid, Spain; Ingenasa (e), Madrid, Spain.
Sero-evidence of exposure to infectious disease agents in free-ranging Iberian lynx
| Sierra Morena (%) | Doñana NP (%) | Total (%) | |
|---|---|---|---|
|
| 11.7 (2/17) | 61.0 (19/31) | 44.0 (21/48) |
| Feline herpesvirus | 6.2 (1/16) | 13.8 (4/29) | 11.1 (5/45) |
| Feline calicivirus | 6.2 (1/16) | 3.6 (1/28) | 4.5 (2/44) |
| Feline parvovirus | 6.2 (1/16) | 0 (0/21) | 2.6 (1/37) |
| Feline coronavirus | 0 (0/16) | 0 (0/21) | 0 (0/37) |
| Feline leukaemia virus | 0 (0/17) | 0 (0/21) | 0 (0/38) |
| Feline immunodeficiency virus | 0 (0/17) | 0 (0/21) | 0 (0/38) |
| Canine distemper virus | 0 (0/16) | 0 (0/21) | 0 (0/37) |
Prevalence in percent (positive/sampled)
Levels of antibody titers to Toxoplasma gondii in eight Iberian lynx that were sampled multiple times at different ages during their life
| Name | Juvenile | Sub-adult | Sub-adult, sampled later | Adult | Adult, sampled ≥1 year later |
|---|---|---|---|---|---|
| Ajoli | – | 1:128 (1991) | – | 1:1024 (1992) | – |
| Algaida | – | – | – | 1:2048 (1991) | 1:256 (1996) |
| Barro | – | – | – | Neg (1996) | 1:128 (1997) |
| Borja | – | – | – | 1:512 (1993) | 1:256 (1995) |
| Escarlata | – | – | – | 1:128 (1994) | Neg (1996) |
| Ganga | Neg (1989) | – | – | 1:256 (1991) | 1:256 (1992) |
| Pepe | 1:128 (1993) | 1:128 (1994) | – | – | – |
| Uda | – | Neg (1996) | 1:64 (1997) | – | – |
The sampling year is shown in parentheses.